Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016

被引：0
|
作者：
Roberta Rudà
Alessia Pellerino
Andrea Pace
Carmine Maria Carapella
Cristina Dealis
Manuela Caroli
Marina Faedi
Lorenzo Bello
Enrica Migliore
Giulia Marchese
Luca Bertero
Paola Cassoni
Riccardo Soffietti
机构：
[1] University and City of Health and Science Hospital,Department of Neuro
[2] Cancer Institute,Oncology
[3] Regional Hospital,Department of Neurosurgery
[4] Regional Hospital,Department of Medical Oncology
[5] Regional Hospital,Department of Neurosurgery
[6] University of Milan,Department of Medical Oncology
[7] University of Turin,Department of Neurosurgery
[8] University and City of Health and Science Hospital,Unit of Cancer Epidemiology (CPO Piemonte)
来源：
Journal of Neuro-Oncology | 2019年 / 145卷
关键词：
Grade II gliomas; WHO 2016; Oligodendrogliomas IDH-mutant and 1p/19q codeleted; Temozolomide; Response; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：115 / 123
页数：8
相关论文
共 24 条
  • [1] Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016
    Ruda, Roberta
    Pellerino, Alessia
    Pace, Andrea
    Carapella, Carmine Maria
    Dealis, Cristina
    Caroli, Manuela
    Faedi, Marina
    Bello, Lorenzo
    Migliore, Enrica
    Marchese, Giulia
    Bertero, Luca
    Cassoni, Paola
    Soffietti, Riccardo
    JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (01) : 115 - 123
  • [2] EFFICACY OF INITIAL TEMOZOLOMIDE FOR HIGH-RISK LOW GRADE GLIOMAS IN A PHASE II AINO (ITALIAN ASSOCIATION FOR NEURO-ONCOLOGY) STUDY: A POST-HOC ANALYSIS WITHIN MOLECULAR SUBGROUPS OF WHO 2016
    Ruda, Roberta
    Pellerino, Alessia
    Pace, Andrea
    Carapella, Carmine Maria
    Dealis, Cristina
    Caroli, Manuela
    Faedi, Marina
    Bello, Lorenzo
    Migliore, Enrica
    Marchese, Giulia
    Bertero, Luca
    Cassoni, Paola
    Soffietti, Riccardo
    NEURO-ONCOLOGY, 2019, 21 : 16 - 17
  • [3] Initial temozolomide for high-risk low-grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis of the efficacy within molecular subgroups of WHO 2016
    Franchino, F.
    Pellerino, A.
    Bruno, F.
    Bertero, L.
    Soffietti, R.
    Ruda, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 389 - 389
  • [4] Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016 (vol 145, pg 115, 2019)
    Ruda, Roberta
    Pellerino, Alessia
    Pace, Andrea
    Carapella, Carmine Maria
    Dealis, Cristina
    Caroli, Manuela
    Faedi, Marina
    Bello, Lorenzo
    Migliore, Enrica
    Marchese, Giulia
    Bertero, Luca
    Cassoni, Paola
    Soffietti, Riccardo
    JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (03) : 593 - 593
  • [5] Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016
    Roberta Rudà
    Alessia Pellerino
    Andrea Pace
    Carmine Maria Carapella
    Cristina Dealis
    Manuela Caroli
    Marina Faedi
    Lorenzo Bello
    Enrica Migliore
    Giulia Marchese
    Luca Bertero
    Paola Cassoni
    Riccardo Soffietti
    Journal of Neuro-Oncology, 2019, 145 : 593 - 593
  • [6] ALTERNATING WEEKLY TEMOZOLOMIDE AS INITIAL TREATMENT FOR PROGRESSIVE LOW-GRADE OLIGODENDROGLIAL TUMORS: A PHASE II AINO (ITALIAN ASSOCIATION FOR NEURO-ONCOLOGY) STUDY
    Soffietti, Riccardo
    Roda, Roberta
    Trevisan, Elisa
    Laguzzi, Elena
    Picco, Elisabetta
    Guarneri, Dainele
    Caroli, Manuela
    Crippa, Flavio
    NEURO-ONCOLOGY, 2008, 10 (05) : 838 - 838
  • [7] TEMOZOLOMIDE (TMZ) 1 WEEK ON/1 WEEK OFF AS INITIAL TREATMENT FOR HIGH RISK LOW GRADE OLIGODENDROGLIAL TUMORS: A PHASE II AINO (ITALIAN ASSOCIATION FOR NEURO-ONCOLOGY) STUDY
    Pellerino, A.
    Franchino, F.
    Pace, A.
    Carapella, C.
    Dealis, C.
    Caroli, M.
    Faedi, M.
    Bomprezzi, C.
    Ruda, R.
    Soffietti, R.
    NEURO-ONCOLOGY, 2017, 19 : 21 - 21
  • [8] PROTRACTED LOW DOSE TEMOZOLOMIDE (TMZ) AS INITIAL TREATMENT FOR PROGRESSIVE LOW-GRADE OLIGODENDROGLIAL TUMORS: A PHASE II AINO (ITALIAN ASSOCIATION FOR NEURO-ONCOLOGY) STUDY
    Trevisan, E.
    Laguzzi, E.
    Guarneri, D.
    Bomprezzi, C.
    Caroli, M.
    Leoncini, B.
    Soffietti, R.
    Ruda, R.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1069 - 1069
  • [9] DOSE-DENSE TEMOZOLOMIDE AS INITIAL TREATMENT FOR PROGRESSIVE LOW GRADE OLIGODENDROGLIAL TUMORS: A MULTICENTER PHASE II STUDY OF THE AINO (ITALIAN ASSOCIATION OF NEURO-ONCOLOGY)
    Ruda, R.
    Bertero, L.
    Trevisan, E.
    Pace, A.
    Carapella, C.
    Dealis, C.
    Caroli, M.
    Faedi, M.
    Bomprezzi, C.
    Soffietti, R.
    NEURO-ONCOLOGY, 2012, 14 : 11 - 11
  • [10] DOSE DENSE TEMOZOLOMIDE (TMZ) AS INITIAL TREATMENT FOR HIGH-RISK OLIGODENDROGLIAL TUMORS: LONG-TERM RESULTS OF A PHASE II AINO (ITALIAN ASSOCIATION FOR NEURO-ONCOLOGY) STUDY
    Soffietti, Riccardo
    Pellerino, Alessia
    Pace, Andrea
    Carapella, Carmine
    Dealis, Cristina
    Caroli, Manuela
    Faedi, Marina
    Bello, Lorenzo
    Ruda, Roberta
    NEURO-ONCOLOGY, 2017, 19 : 2 - 2
123